An optogenetic approach for regulating human parathyroid hormone secretion.

Area of Science:

• Endocrinology
• Molecular Biology
• Optogenetics

Background:

• Parathyroid hormone (PTH) is vital for calcium and phosphorus balance.
• Secondary hyperparathyroidism (SHPT) involves decreased calcium-sensing receptors (CaSR) and excessive PTH secretion.
• Precise control over PTH secretion and its molecular mechanisms remain unclear.

Purpose of the Study:

• To establish an optogenetic approach to inhibit PTH secretion in human hyperplastic parathyroid cells, bypassing CaSR.
• To investigate the molecular mechanisms underlying optogenetically controlled PTH secretion.
• To evaluate the therapeutic potential of this approach in preventing SHPT-associated bone loss.

Main Methods:

• Developed an optogenetic system to target parathyroid cells.
• Utilized light stimulation to modulate intracellular calcium levels and PTH synthesis/secretion.
• Assessed the impact of long-term, pulsatile PTH secretion on bone remodeling in a mouse model of SHPT.

Main Results:

• Optogenetic stimulation successfully elevated intracellular calcium and inhibited PTH synthesis and secretion in human parathyroid cells.
• Light-induced pulsatile PTH secretion in mice prevented bone loss associated with hyperplastic parathyroid tissue.
• The observed effects were mediated by opsin expression in parathyroid and other parathyroid tissue cells.

Conclusions:

• Optogenetics offers a novel strategy to precisely regulate PTH secretion by bypassing CaSR.
• This approach demonstrates potential for managing SHPT and preventing associated bone loss.
• The study highlights the role of light-activated opsins in controlling endocrine function and metabolic bone disease.